Your session is about to expire
← Back to Search
Behavioral Intervention
Coach McLungs Intervention for Asthma
N/A
Recruiting
Led By Hazel Tapp, PhD
Research Sponsored by Atrium Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Established mild, moderate, or severe persistent asthma
English or Spanish speaking.
Must not have
Decisional impaired or mentally incompetent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test how well an online asthma education and decision-making tool works when incorporated into primary care.
Who is the study for?
This trial is for children and teens aged 5-17 with mild to severe persistent asthma who can communicate in English or Spanish. It's not suitable for those who have decision-making impairments or are mentally incompetent.
What is being tested?
The study tests the Coach McLungsSM intervention, a virtual tool designed to help manage asthma through education and clinical support. The effectiveness will be measured by looking at emergency visits, hospital stays, and oral steroid use due to asthma.
What are the potential side effects?
Since Coach McLungsSM is an educational and supportive intervention rather than a medication, it does not have traditional side effects. However, there may be indirect effects on patient behavior or healthcare utilization.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with persistent asthma.
Select...
I speak English or Spanish.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am able to make my own health decisions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Asthma
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
Coach McLungs not yet implemented in practice
Group II: InterventionActive Control1 Intervention
Coach McLungs Implemented in Practice
Find a Location
Who is running the clinical trial?
Atrium HealthLead Sponsor
121 Previous Clinical Trials
32,233 Total Patients Enrolled
2 Trials studying Asthma
1,070 Patients Enrolled for Asthma
Wake Forest University Health SciencesLead Sponsor
1,394 Previous Clinical Trials
2,457,336 Total Patients Enrolled
7 Trials studying Asthma
41,942 Patients Enrolled for Asthma
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,931 Previous Clinical Trials
47,764,008 Total Patients Enrolled
282 Trials studying Asthma
111,928 Patients Enrolled for Asthma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I speak English or Spanish.I have been diagnosed with persistent asthma.I am able to make my own health decisions.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger